Get started
Author

Marjon Cnossen

Observed name: Cnossen, Marjon
OpenAlex ID: A5137477567
Transcriptional and functional profiling identifies inflammation and endothelial-to-mesenchymal transition as potential drivers for phenotypic heterogeneity within a cohort of endothelial colony forming cells
2024 · Sebastiaan N.J. Laan, Suzan de Boer, et al. · Journal of Thrombosis and Haemostasis · 10
Proteomic analysis indicates lower abundance of platelet α-granule proteins in Glanzmann thrombasthenia
2025 · Minka Zivkovic, Tatiana M. Shamorkina, et al. · Journal of Thrombosis and Haemostasis · 4
PDF
Proteolytic signatures of coagulation identified by plasma peptidomics
2025 · Jessica Del Castillo Alferez, Alette Kooiker, et al. · Journal of Thrombosis and Haemostasis · 3
A rapid whole-blood adenosine triphosphate secretion test can be used to exclude platelet-dense granule deficiency
2025 · Minka Zivkovic, Roger E.G. Schutgens, et al. · Journal of Thrombosis and Haemostasis · 2
PDF
Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist
2024 · Minka Zivkovic, Elisabeth Pols - van Veen, et al. · Research and Practice in Thrombosis and Haemostasis · 1
PDF
PB2098 Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: cost-effectiveness analysis of the DosEmi study
2026 · Diaz Prameyllawati, Amber de Vos, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
PB3431 Challenges for pharmacokinetic-guided dosing of plasma-derived VWF/FVIII 1:1 concentrate: insights from a population pharmacokinetic model
2026 · Jelien den Hollander, Sjoerd Koopman, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
OC 20.5 Improving information provision in rare bleeding disorders
2026 · Caroline Mussert, Annebelle Nooteboom, et al. · Research and Practice in Thrombosis and Haemostasis
OC 53.1 Age-related normalization of Von Willebrand Factor Levels Does Not Eliminate Surgical Bleeding Risk in Type 1 Von Willebrand Disease
2026 · Robin Blok, Emily Somohardjo, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
PB3359 Accurately inferring missing factor VIII concentrate dosing information from health-record data in patients with haemophilia A
2026 · Alexander Janssen, Ron Mathot, et al. · Research and Practice in Thrombosis and Haemostasis
PB2254 The Hemophilia Health Journey: Exploring the Experiences and Unmet Care Needs of Young Children with Hemophilia and their Caregivers
2026 · Caroline Mussert, Eva Kempers, et al. · Research and Practice in Thrombosis and Haemostasis
OC 78.2 Navigating the Transfer of Care in Rare Bleeding Disorders: Experiences and Needs from Adolescents and Young Adults, their Caregivers and Healthcare Providers
2026 · Caroline Mussert, Lorynn Teela, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
PB2279 Pain during emicizumab administration is significant in people with hemophilia A
2026 · Amber de Vos, Konrad van der Zwet, et al. · Research and Practice in Thrombosis and Haemostasis
PB3409 The prevalence of enhanced VWF clearance in type 2A and 2M VWD and the utility of the VWFpp/VWF:Ag ratio
2026 · Emily Somohardjo, Robin Blok, et al. · Research and Practice in Thrombosis and Haemostasis
PB3421 Real-world pharmacokinetics of a 1:1 ratio von Willebrand factor/factor VIII concentrate in the perioperative setting
2026 · Sjoerd Koopman, Jelien den Hollander, et al. · Research and Practice in Thrombosis and Haemostasis
Modifying quality and equity of care: emerging roles of genetic disease modifiers in β-hemoglobinopathies
2026 · Panayiota L. Papasavva, Atinuke M. Dosunmu-Ogunbi, et al. · Blood Advances
Hemofilie
2014 · Loomans, JI, Lock, Janske, et al. · EUR Research Repository (Erasmus University Rotterdam)
Works count: 17
Citation count: 20
H-index: 3
I10-index: 1
Year
Topic
Type